Stroke Prevention in Atrial Fibrillation

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
For this podcast, produced by the American Society of Health-System Pharmacists, 3 pharmacists were interviewed on issues relating to preventing stroke in atrial fibrillation. The interviewees are: James Kalus, PharmD, senior manager of patient care services in the department of pharmacy at Henry Ford Hospital in Detroit; Cynthia Sanoski, PharmD, chair and associate professor in the department of pharmacy practice at Jefferson School of Pharmacy at Thomas Jefferson University in Philadelphia; and Nancy Shapiro, PharmD, clinical associate professor in the department of pharmacy practice at the University of Illinois at Chicago College of Pharmacy.
 
To listen to this podcast, click here.
Related Articles
The FDA has approved a new treatment for adults who experience bleeding episodes from a rare and potentially life-threatening form of hemophilia.
Three individuals who were in close contact with an Ebola patient have been placed under quarantine.
It is compulsory for pharmacists to counsel all patients receiving opioids, evaluate the potential benefit of a naloxone reversal device, and contact the opioid prescriber if such a device is deemed appropriate.
While there is currently no standard treatment, vaccine, or cure for Ebola, there are still some experimental treatments in 3 drug class with more to come.
Latest Issues
$auto_registration$